Time to go All-In on Celsion?
Celsion (CLSN) is a great story stock. It recently announced their Phase III trial results for liver cancer will be released by the end of January 2013. This will be a top-line release of a multinational, double-blind, placebo-controlled study of primary liver cancer. The results could make or break the company as its future pipeline is dependent on ThermoDox succeeding.
This upcoming catalyst is likely to have a huge impact on the company's valuation. The company has a current market cap of $287 million, but this will likely be drastically different by the end of the month. The CEO of Celsion has stated that this liver cancer treatment will have the potential to generate yearly revenues of $1 billion.
Mastery Bottom Line
Look for a good entry point before betting the farm on CLSN. Shares could dip down to touch the 50 day MA due to some investors not wanting to risk holding through the FDA results. A $7 - $7.50 share price would provide a great buying opportunity.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Algos Gone Wild: BABA "Glitch" Halted 7 Seconds, "100s Of Flash Crashes" Into Close | ZeroHedge
- Meanwhile, In Front Of Apple Stores In New York And Around The World... | ZeroHedge
- One Of These Things Is Not Like The Other | ZeroHedge
- Gold - Watch the €1000 Level | Financial Sense
- Was Scottish Vote Rigging Caught On Tape? | ZeroHedge
- Congress Brings 'Atlas Shrugged' To America With This New Bill | ZeroHedge
- Martin Armstrong: Capital Herding Into the U.S., Likely to Push Dollar, Stocks Higher Into Next Year | Financial Sense
The most relevant financial news and articles from the Internets
- Why Bank of America, JPMorgan, Wells Fargo Are Finally Waking Up | TheStreet.com
- Even With Apple's New Security Measures, It's Still Possible To... | Business Insider
- Notable Mergers and... | StreetInsider.com
- Obama Can't Stand The Leader Of The Democratic Party [... | Business Insider
- Hours Before The Alibaba IPO, The NYSE Is Already A Madhouse | Business Insider
- This Guy Will Make Thousands Of Dollars Waiting In Line For People... | Business Insider
- CAMERON SPEAKS: The Scottish Referendum Just Transformed UK... | Business Insider